News
Videos
Conferences
Events
Resources
Subscribe

|Videos|September 22, 2017

Prostate Cancer Screening: A Valuable Tool

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of man.

Prostate Cancer Diagnoses Rise as Death Rate Decline Slows

October 8th 2025

Image of man and doctor.

Active Surveillance or Treatment? Your Guide to Stage 1 Prostate Cancer Options

October 3rd 2025

FDA sign image

All FDA Oncology Approvals From September 2025

BySpencer Feldman

October 1st 2025

The FDA approved the denosumab biosimilars Enoby and Xtrenbo for patients on hormone therapies for breast or prostate cancer that weaken bones: © stock.adobe.com.

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

October 1st 2025

Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary team of healthcare providers.

Why Multidisciplinary Care is Crucial in Prostate Cancer

September 29th 2025

Trending on CURE

FDA Grants Fast Track Designation to ADCE-D01 for Soft Tissue Sarcoma

What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?

Body Image and Sexual Health Challenges After Breast Cancer

Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery

Finding Hope Amidst a Lung Cancer Diagnosis

© 2025 MJH Life Sciences^®

All rights reserved.